Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
+8,600
New +$190K ﹤0.01% 3364
2026
Q1
Sell
-25,300
Closed -$320K 4917
2025
Q4
$320K Buy
25,300
+6,900
+38% +$102K ﹤0.01% 3261
2025
Q3
$283K Sell
18,400
-13,700
-43% -$221K ﹤0.01% 3060
2025
Q2
$505K Buy
+32,100
New +$487K ﹤0.01% 2628
2024
Q4
Sell
-2,100
Closed -$58.8K 5453
2024
Q3
$58.8K Buy
+2,100
New +$59.3K ﹤0.01% 4590
2023
Q4
Sell
-10,700
Closed -$211K 5438
2023
Q3
$211K Buy
+10,700
New +$211K ﹤0.01% 3513

Other funds holding RXO

Walleye Capital's RXO Position: Q2 2026 in Review

Walleye Capital opened a new position in RXO (RXO) in Q2 2026: 12,748 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #3043 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RXO as recently as Q2 2025.

Walleye Capital first reported a position in RXO in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.29M in Q2 2025. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Walleye Capital held 12,748 shares of RXO worth $352K as of Q2 2026.
  • RXO was a new Walleye Capital position in Q2 2026.
  • RXO made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3043 holding.
  • Walleye Capital first reported a position in RXO in Q3 2024 and has held it in 3 quarters since.
  • Walleye Capital's RXO position peaked at $2.29M in Q2 2025.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.